VALFIX Medical

Mitral Valve Repair System

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in June 2016 by Eli Bar and Elad Yaacoby, VALFIX Medical operates with 1–10 employees. The company has raised a total of $8.76 million across eight funding rounds and has secured a fifth consecutive grant from the Israel Innovation Authority in December 2023.

Business overview

VALFIX Medical is a Health Tech & Life Sciences company focused on developing a revolutionary transcatheter mitral valve repair system. Its core technology aims to convert open-heart valve surgery into a less invasive transcatheter procedure, addressing severe functional mitral regurgitation (FMR) in millions of patients who currently lack viable treatment options. The company operates within the Medical Devices, Medical Treatment & Therapeutics sectors, serving healthcare providers globally.

Strategic signal

In March 2024, VALFIX Medical Inc. announced the issuance of a new U.S. patent for its mitral valve repair technology. This patent issuance signals continued innovation and intellectual property protection for the company's core product, reinforcing its position in the competitive medical device market and potentially enhancing its value proposition to investors and strategic partners.

Company Intelligence Q&A

What is VALFIX Medical's primary focus?
VALFIX Medical is developing a transcatheter mitral valve repair system designed to treat severe functional mitral regurgitation, aiming to provide a less invasive alternative to open-heart surgery.
When was VALFIX Medical founded?
VALFIX Medical was founded in June 2016 by Eli Bar and Elad Yaacoby.
Has VALFIX Medical secured any recent grants?
In December 2023, VALFIX Medical Inc. secured its fifth consecutive grant from the Israel Innovation Authority.
What significant intellectual property milestone did VALFIX Medical achieve recently?
In March 2024, VALFIX Medical Inc. announced the issuance of a new U.S. patent for its mitral valve repair technology.
Which investors participated in VALFIX Medical's September 2019 funding round?
In September 2019, VALFIX Medical secured investment from Life Science Angels (LSA) and KYTO.

External links